Reference number : 276-2021-2022-Q2-00077, amendment number : , agreement type : C, recipient legal name : Axem Neurotechnology Inc.|Axem Neurotechnology Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3J 3K5, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivité des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 218689, agreement title french : 218689, agreement number : 218689, agreement value : 100000.0, agreement start date : 2021-07-28, agreement end date : 2022-03-31, description english : Conduct clinical trials on prototypes to demonstrate clinical value, description french : Mener des essais cliniques sur les prototypes pour prouver la valeur clinique, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique